Daniel W. Coyne, MD

Professor of Medicine, Nephrology/Internal Medicine

Interests: Providing comprehensive care to patients with chronic kidney disease (CKD), hypertension, proteinuria, glomerular diseases, inherited kidney diseases, fluid and electrolyte disorders and care for patients requiring chronic dialysis.

Click to see this content

Additional Titles

  • Director, Medical Multispecialty Outpatient Group, Center for Advanced Medicine
  • Director of Hemodialysis, Chromalloy American Kidney Center

Location

Patients seen at

Center for Advanced Medicine

Chromalloy Kidney Center

DaVita Fenton

DaVita Lamplighter

DaVita South City Dialysis

Home Dialysis South

Education

  • Bachelor of Arts, Chemistry: St. Louis University, St. Louis, MO (1979)
  • Doctor of Medicine: Case Western Reserve School of Medicine, Cleveland, OH (1983)
  • Resident in Internal Medicine: Emory University, Atlanta, GA (1986)
  • Fellow in Nephrology: Washington University School of Medicine, St. Louis, MO (1989)

Board Certifications

  • Internal Medicine, 1986
  • Nephrology, 1988

Recognition

Member, American Society of Nephrology
Member, International Society of Nephrology

Clinical Interests

My clinical interests include providing comprehensive care to patients with chronic kidney disease (CKD), hypertension, proteinuria, glomerular diseases, inherited kidney diseases, fluid and electrolyte disorders, and care for patients requiring chronic dialysis.

Research Interests

My research interests focus on anemia and renal bone disease, problems commonly seen among patients with CKD. My anemia research has focused on the proper use of epoetin and similar drugs, the role of iron in proper management, and defining the significant clinical risks and limited benefits of aggressive treatment of anemia in CKD. My research has also explored the value of treatments for renal metabolic bone disease, also known as CKD-MBD. Studies have included human trials of paricalcitol, cinacalcet, ergocalciferol, niacinamide, and various phosphate binders.

First Name

Daniel

Middle

W.

Last Name

Coyne

Degree(s)

MD

Primary Title/Role

Professor of Medicine, Nephrology/Internal Medicine

Phone

314-362-7603

Fax

314-747-5213

Additional Information

Interests: Providing comprehensive care to patients with chronic kidney disease (CKD), hypertension, proteinuria, glomerular diseases, inherited kidney diseases, fluid and electrolyte disorders and care for patients requiring chronic dialysis.

Additional Titles

  • Director, Medical Multispecialty Outpatient Group, Center for Advanced Medicine
  • Director of Hemodialysis, Chromalloy American Kidney Center

Office/Institution

Division of Renal Diseases

Washington University School of Medicine

660 S. Euclid Ave, CB 8129

St. Louis, MO 63110

Education

  • Bachelor of Arts, Chemistry: St. Louis University, St. Louis, MO (1979)
  • Doctor of Medicine: Case Western Reserve School of Medicine, Cleveland, OH (1983)
  • Resident in Internal Medicine: Emory University, Atlanta, GA (1986)
  • Fellow in Nephrology: Washington University School of Medicine, St. Louis, MO (1989)

Board Certifications

  • Internal Medicine, 1986
  • Nephrology, 1988

Recognition

Member, American Society of Nephrology
Member, International Society of Nephrology

Clinical Interests

My clinical interests include providing comprehensive care to patients with chronic kidney disease (CKD), hypertension, proteinuria, glomerular diseases, inherited kidney diseases, fluid and electrolyte disorders, and care for patients requiring chronic dialysis.

Research Interests

My research interests focus on anemia and renal bone disease, problems commonly seen among patients with CKD. My anemia research has focused on the proper use of epoetin and similar drugs, the role of iron in proper management, and defining the significant clinical risks and limited benefits of aggressive treatment of anemia in CKD. My research has also explored the value of treatments for renal metabolic bone disease, also known as CKD-MBD. Studies have included human trials of paricalcitol, cinacalcet, ergocalciferol, niacinamide, and various phosphate binders.